[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.159.180. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1962

Biochemical Alterations of Preserved BloodResults in Two Different Citrate Solutions (ACD and CPD)

Author Affiliations

DENVER
Post-Doctoral Research Fellow, National Institutes of Health, Bethesda, Md. (Dr. Schechter).; From the Departments of Surgery, the University of Colorado School of Medicine, Denver, and the Jefferson Medical College, Philadelphia.

Arch Surg. 1962;84(3):269-276. doi:10.1001/archsurg.1962.01300210003001
Abstract

Introduction  Sodium citrate was recommended in 1914 as an anticoagulant for the preservation of blood. Satisfactory erythrocyte survival could be maintained for only 5 days in this solution. Critical decomposition of blood was held in abeyance up to a 12-day limit by the incorporation of dextrose as a pabulum for continuing cellular metabolism during refrigerated storage. The viability period was extended further, to 21 days, during World War II by the addition of a citric acid buffering substrate. This triple formula constitutes the now widely used acid-citrate-dextrose (ACD) solution.During storage, serious biochemical changes occur in ACD bank blood which convert it into a potentially hazardous therapeutic agent. While convenient for routine use to combat anemia or moderate hypovolemia, blood preserved in ACD may prove dangerous or even lethal when administered in large amounts, as, for example, in exchange transfusions, massive replacement therapy, or the priming of extracorporeal circuits such

First Page Preview View Large
First page PDF preview
First page PDF preview
×